Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Drugs Made In America Acquisition Corp
Interest Income Expense
Drugs Made In America Acquisition Corp
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
Interest Income Expense
$8.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Interest Income Expense
-$460.4m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-12%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Interest Income Expense
$29.1m
|
CAGR 3-Years
3 086%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Interest Income Expense
-$1m
|
CAGR 3-Years
87%
|
CAGR 5-Years
68%
|
CAGR 10-Years
38%
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Drugs Made In America Acquisition Corp
Glance View
Drugs Made In America Acquisition Corp. is a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is incorporated as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus its search for business combination targets in the pharmaceutical industry.
See Also
What is Drugs Made In America Acquisition Corp's Interest Income Expense?
Interest Income Expense
8.8m
USD
Based on the financial report for Dec 31, 2025, Drugs Made In America Acquisition Corp's Interest Income Expense amounts to 8.8m USD.
